We invite you to read the sources below to learn more about CLL therapies. 

HealthTree News Articles and Pages

• CLL Genetic Features
• “Off-the-Shelf" CAR T-Cell Therapy for CLL
• Relapsed/Refractory CLL Treatment Options
• What is Sonrotoclax for CLL?
• Zanubrutinib + Venetoclax for High-Risk First-Time Treated CLL
• Years on, Ibrutinib + Venetoclax Keeps High-Risk CLL in Remission
• What If Venetoclax Stops Working?
• Venetoclax for CLL: Treatment Options and Patient Outcomes
• What are BTK Inhibitors for CLL?
• Bispecific Antibodies for CLL Webinar
• New CLL Medicines in Clinical Trials: BTK Degraders
• Making the Choice in CLL: Acalabrutinib or Zanubrutinib
• First-Time Treated CLL? Learn About the New Combination of Pirtobrutinib + Obinutuzumab
• First-Ever FDA-Approved CAR T-Cell Therapy for R/R CLL: Liso-cel (Breyanzi)
• Do CLL Patients Prefer Fixed-Duration or Continuous-Duration Therapy?

HealthTree University Videos

• When should a patient start their treatment for CLL?
• What treatment options are available for patients with CLL?
• What is the goal of therapy for CLL?
• How are treatment plans developed for patients with CLL?
• What CLL patients need treatment right away?
• What symptoms may indicate the need to start treatment?
• What Types of Treatment Options are Available for CLL Patients?
• What types of conversations should patients have with their doctors?
• What are some of the major side effects of treatment that patients should be prepared for?
• If I don't see any side effects from my medication, does that mean it isn't working?
• How can I prepare for the end of treatment, both emotionally and practically?
• Clinical Trials & Experimental Treatments: Opportunities for Patients
• Are there any clinical trials or experimental treatments patients may be eligible for
• Is fixed-duration therapy or continuous-duration therapy the best option for a patient?
• All about BTK Inhibitors
• All About Venetoclax

HealthTree Webinars 

• What are the Current CLL Clinical Trials? With Ryan Jacobs, MD
• How Are CLL Medicines' Side Effects Managed? with Deborah Stephens, DO
• Relapsed/Refractory CLL Treatment Options with Dr. Kerry Rogers
• Fixed-Duration vs. Continuous-Duration CLL Medicines with Dr. Alvaro Alencar
• All About Bispecific Antibodies for CLL with Dr. Adam Kittai
• A Personalized CLL Vaccine: NeoVax with Inhye Ahn, MD Dana-Farber Cancer Institute
• How Can CLL Clinical Trials Help Me? Learn from Dr. Danielle Brander of Duke Cancer Institute
• Finding Financial Support and Resources for Your CLL Treatment
• Infection Prevention for CLL Patients with Dr. Meghan Thompson